Predictive Genetic Counselling Market Report 2025

The predictive genetic counselling market size has grown rapidly in recent years. It will grow from $3.6 billion in 2024 to $4.19 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to the increasing popularity of ancestry and genealogy services, growing utilization of genetic data for research, rising demand for paternity and relationship testing, expanding use of pharmacogenomics in drug development, and the proliferation of private genetic counseling centers.

The predictive genetic counselling market size is expected to see rapid growth in the next few years. It will grow to $7.59 billion in 2029 at a compound annual growth rate (CAGR) of 16%. The growth in the forecast period can be attributed to the increasing integration of artificial intelligence in genetic risk assessment, rising adoption of employer-sponsored genetic health programs, expanding collaborations between genetic companies and healthcare providers, greater availability of at-home sample collection kits, and growing demand for reproductive and preconception genetic counseling. Major trends in the forecast period include advancements in multi-omics approaches for comprehensive risk assessment, development of chatbot-based genetic counseling interfaces, implementation of blockchain for secure genetic data sharing, innovation in wearable devices connected to genetic health insights, and creation of multilingual genetic counseling platforms.

The growing prevalence of genetic disorders is expected to drive growth in the predictive genetic counselling market. Genetic disorders, caused by DNA changes or defects, can significantly affect growth, development, and overall health. Rising parental age contributes to a higher likelihood of genetic mutations, increasing demand for early risk assessment services that help individuals understand their chances of inheriting or passing on such conditions. For example, in October 2024, the Cystic Fibrosis Trust reported that the number of registered cystic fibrosis patients in the UK increased to 11,318 in 2023, up from 11,148 in 2022.

Companies in the predictive genetic counselling market are advancing solutions like predictive genetic testing services to enable early disease risk detection, personalized care, and informed clinical decision-making. Predictive genetic testing analyzes an individual’s DNA to identify variations associated with an elevated risk of developing inherited conditions. In August 2024, Genetic Technologies Limited, an Australia-based genomics company, launched the geneType Risk Assessment test - a multi-risk screening tool evaluating the likelihood of conditions such as breast, colorectal, ovarian, and prostate cancer, as well as coronary artery disease and type 2 diabetes. It integrates polygenic risk scores with non-genetic factors like age, family history, and clinical measurements to deliver personalized, actionable risk profiles and preventive care recommendations across 42 countries.

In January 2022, Exact Sciences Corp., a US-based molecular diagnostics company, acquired PreventionGenetics for $190 million. This acquisition strengthened Exact Sciences’ hereditary cancer testing capabilities, expanding its germline genetic testing portfolio and allowing the company to offer both hereditary and acquired cancer risk assessments from a single platform. PreventionGenetics specializes in susceptibility and carrier genetic testing.

Major players in the predictive genetic counselling market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, Natera Inc, Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, 23andMe Holding Co, Color Genomics Inc, deCODE genetics, Centogene NV, Admera Health LLC, Mapmygenome, Exact Sciences Corporation, BGI Group.

North America was the largest region in the predictive genetic counselling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in predictive genetic counselling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the predictive genetic counselling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Predictive genetic counseling is a service that assesses an individual’s likelihood of developing or transmitting genetic disorders, often before any symptoms appear. This process involves analyzing genetic test results, reviewing family history, and explaining potential health outcomes. Its primary objectives are to support informed healthcare and lifestyle decisions, enable early disease prevention, and provide emotional guidance for managing genetic risk information.

The main types of predictive genetic counseling services include risk assessment, carrier testing, predictive testing, and others. Risk assessment services collect personal and family health histories, existing genetic test data, and factors such as ethnicity to estimate an individual’s probability of developing a genetic disorder. These services encompass various predictive tests, including genetic susceptibility tests, predictive diagnostics, and population screening, and can be delivered through in-person consultations or online platforms. Predictive genetic counseling is applied in numerous areas, such as consumer genomics, breast and ovarian cancer, cardiovascular screening, diabetes monitoring, colon cancer, neurodegenerative diseases like Parkinson’s and Alzheimer’s, prostate and urologic screening, orthopedic and musculoskeletal conditions, among others. Key end-users include hospitals and clinics, diagnostic laboratories, research and academic institutions, and other healthcare organizations.

The predictive genetic counselling market research report is one of a series of new reports that provides predictive genetic counselling market statistics, including predictive genetic counselling industry global market size, regional shares, competitors with a predictive genetic counselling market share, detailed predictive genetic counselling market segments, market trends and opportunities, and any further data you may need to thrive in the predictive genetic counselling industry. The predictive genetic counselling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The predictive genetic counselling market includes revenues earned by entities through the pharmacogenomic testing, prenatal testing, newborn screening, and lifestyle or prevention planning. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.